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ligation and simultaneous arteriovenous ﬁstula
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Andrew E. Leake, MD,a Steven A. Leers, MD,a Thomas Reifsnyder, MD,b and Ellen D. Dillavou, MD,a
Pittsburgh, Pa; and Baltimore, Md
Dialysis access-related ischemic steal syndrome is a well-recognized dialysis access complication. When severe, manifes-
tations include rest pain, hand dysfunction, and tissue loss. Dialysis access attempts on the affected extremity are usually
abandoned after a diagnosis of steal syndrome, and patients are often left catheter-dependent. Prophylactic distal
revascularization with interval ligation has been described in patients at high-risk for steal syndrome. We present our
experience with prophylactic distal revascularization with interval ligation performed simultaneously with arteriovenous
ﬁstula creation to prevent the recurrence in ﬁve patients and review the current body of literature supporting its use.
(J Vasc Surg Cases 2015;1:87-9.)Dialysis access-steal syndrome (DASS) is a well-
recognized access-related complication and occurs in up
to 5% to 8% of dialysis patients.1,2 When DASS is severe,
manifestations can include rest pain, hand dysfunction,
and tissue loss. These patients require prompt surgical
intervention to improve hand perfusion and prevent per-
manent hand dysfunction or amputation, or both. Several
surgical procedures have been described to surgically treat
DASS after access creation. Early reports of managing
DASS have included access ligation; however, this left
patients without a permanent access. Schanzer et al3 origi-
nally described in 1988 a procedure that could resolve
distal ischemia while still maintaining access patency, distal
revascularization, and interval ligation (DRIL).
Several factors have been associated with an increased
risk of DASS, including anatomic considerations (including
peripheral vascular disease), brachial artery-based access,4
and lower extremity access.5 Among the comorbidities
that have also been associated with DASS are peripheral
vascular disease, diabetes, female gender, and hyperten-
sion.4,6 Finally, patients who have previously experienced
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://dx.doi.org/10.1016/j.jvsc.2015.02.003With the durability and success of the DRIL procedure,
there may be a role for prophylactic DRIL (pDRIL) in pa-
tients who have are high risk to developDASS. The available
literature for pDRILs is extremely limited. This study was
performed to report outcomes of pDRILs when performed
simultaneously with arteriovenous ﬁstula (AVF) creation.
METHODS
A retrospective review was performed of all patients
who underwent a planned pDRIL and simultaneous hemo-
dialysis access procedure (Fig) from July 2003 to July 2014
at two academic institutions. No patients had active DASS
symptoms. The University of Pittsburgh’s Institutional Re-
view Board approved this study before data collection, and
a waiver of consent was granted because all data were
already in existence and the study exhibited minimal risk.
Descriptive statistics included age, sex, comorbid condi-
tions, prior episodes of DASS, and operative details, and
patient outcomes were reviewed and reported.
A literature search was performed using PubMed, identi-
fying any case reports or case series of prophylactic or preemp-
tiveDRILs.Allmajor studies reportingDRILoutcomeswere
also reviewed to identify cases of prophylactic placement.
RESULTS
Five patients (three women) underwent a simultaneous
DRIL and AVF placement. All patients previously developed
DASS after a brachial artery AVF, surgically treated with
ligation. Patients were a mean age of 64 years (range, 39-
80 years). All patients had peripheral vascular disease, dia-
betes mellitus, hypertension, and end-stage renal disease
and were receiving hemodialysis through a tunneled dialysis
catheter (TDC). The mean number of previous access pro-
cedures was 2.6 per patient (excluding access ligation). All
patients had a preoperative angiogram that did not demon-
strate proximal disease or severe forearm occlusive disease.
All new AVF were brachial based and placed on the
same side as the patient’s previous episode of steal. AVF87
Fig. Intraoperative image shows new brachiocephalic arterio-
venous ﬁstula (AVF) creation (white arrow), brachial-brachial bypass
(black arrow), and interval brachial artery ligation (yellow arrow).
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1 brachial vein transposition, and 1 brachial artery-to-
axillary vein graft using translocated femoral vein. DRIL
bypass conduits included saphenous vein in three and
basilic vein in two.
There were no 30-day complications or development of
perioperative DASS. At the last follow up (mean, 244 days),
all AVFs were functional and the pDRILs remained patent,
with a mean access maturation time of 56 days. Two patients
died in the follow-up period (postoperative days 40 and 83)
of causes unrelated to their dialysis access.
DISCUSSION
This study reviewed ﬁve patients who were at high-risk
for the development of DASS due to a history of DASS af-
ter a previous access procedure in the same arm, leading to
access ligation. These patients are very challenging cases to
providing permanent dialysis access.
The literature review identiﬁed one case report7 and
two retrospective DRIL series in which pDRIL patients
were included.8,9 The ﬁrst description of a pDRIL was by
Lebow et al,7 where a patient at high risk for the develop-
ment of steal had intraoperative signs of DASS. They sub-
sequently performed a DRIL procedure, and the patient
did not develop DASS postoperatively. Anaya-Ayala et al8
performed two pDRILs as part of their series. Both were
high-risk due to medical comorbidities and a lower extrem-
ity access conﬁguration. Lastly, Scali et al9 reported the
largest series, with eight patients undergoing pDRIL. Six
of these patients had a history of DASS, whereas the other
two had distal forearm occlusive disease. These patients
were part of a larger series, and details about their out-
comes were not speciﬁed.
A reasonable option in this patient population is leaving
them TDC dependent. DASS patients have severe comor-
bidities and sometimes a limited life expectancy. However,
leaving a functional patient with a reasonable life expec-
tancy TDC dependent is inappropriate due to the known
risk of increased all-cause mortality, fatal infections, and
cardiovascular mortality directly related to TDCs.10The other alternative is to abandon the DASS extrem-
ity and perform the next access procedure in the contralat-
eral arm, using techniques to minimize the risk that DASS
will develop. This may include using a more distal artery for
ﬁstula inﬂow and, hopefully, lowering the risk of ischemia.
Another well-described technique is using the proximal ar-
tery as inﬂow or using the proximalization of arterial inﬂow
technique preoperatively.11
With the published success of the DRIL procedure,2,4
it becomes a favorable option to not only treat DASS but
also prevent its recurrence. pDRILs were placed with no
complications, and all AVFs reached maturation. The
pDRIL was placed in the same extremity as the patient’s
previous steal, with no development of DASS.
DRIL improves DASS symptoms in 80% to 100% of
patients,1,2,9,12,13 and reported bypass primary patency is
95% at 1 year and 78% at 5 years.9 The high rate of resolu-
tion of symptoms and excellent bypass patency has made
the DRIL procedure a popular, durable surgical therapy
for DASS.
pDRIL placement represents an aggressive application
of a procedure with excellent outcomes and patency. Pa-
tients with a history of DASS represent the highest risk of
developing DASS, or better said, the recurrence of
DASS. Lebow et al7 and Anaya-Ayala et al8 performed
pDRILs in patients at high medical risk with good out-
comes. Scali et al9 performed most of their pDRILs to pre-
vent recurrence, but also performed pDRILs in two
patients with forearm occlusive arterial disease. These cases
highlight that carefully selected high-risk DASS patients
can safely undergo access placement with prevention of
DASS with a pDRIL.
The literature includes reports of 16 patients who have
undergone a pDRIL. This is a limited experience and,
therefore, should be reserved for select patients. Despite
the known risk factors for DASS, the patient-speciﬁc risks
are difﬁcult to determine and hard to quantify for patients.
To date, our institutions have reserved pDRIL to prevent
recurrence of DASS after a documented episode. pDRILs
have been reserved for patients who are functional and
will live long enough to beneﬁt from an AVF over a
TDC. pDRIL expands the available access choices in these
patients. Although adding DRIL to the access procedure
presumably increases the overall surgical risks, we did not
observe this. The available literature for thrombotic com-
plications of DRIL bypasses is smaller than this series but
remains a realistic concern, and patients should be
counseled.
CONCLUSIONS
DASS represents a severe complication and a major
obstacle to future dialysis access. In patients with a his-
tory of DASS, a pDRIL at the time of access creation pre-
vents the development of DASS and may be applicable to
other high-risk patients. Further research is needed to
quantify patient’s risk for the development of DASS and
who may therefore beneﬁt from a prophylactic DRIL
procedure.
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